Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial

Hiroki Teragawa1 Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, JapanCorrespondence[email protected]

Takeshi Morimoto2 Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan

Yuichi Fujii1 Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan

Tomohiro Ueda1 Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, JapanView further author information

Mio Sakuma2 Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, JapanView further author information

Michio Shimabukuro3 Deparment of Diabetes, Endocrinology and Metabolism, Fukushima Medical University, Fukushima, JapanView further author information

Osamu Arasaki4 Department of Cardiology, Yuuai Medical Center, Tomigusuku, Okinawa, JapanView further author information

Koichi Node5 Department of Cardiovascular Medicine, Saga University, Saga, JapanView further author information

Takashi Nomiyama6 Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare Ichikawa Hospital, Ichikawa, JapanView further author information

Shinichiro Ueda7 Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Nishihara, Okinawa, JapanView further author information

Your download is now in progress and you may close this window